gastric%20cancer
GASTRIC CANCER
Treatment Guideline Chart
Gastric cancer is the cancer originating in the esophagus, esophagogastric junction and stomach.
Most of gastric cancers are adenocarcinomas, subdivided according to histological appearances into diffuse (undifferentiated) and intestinal (well differentiated) types.
It is the 4th most common cancer and the 2nd most common cause of cancer-related deaths worldwide.
Most common sites of gastric cancer are the proximal lesser curvature, cardia and esophagogastric junction.

Gastric Cancer References

  1. Ajani JA, Bentrem DJ, Besh S, et al. Gastric cancer, version 2.2013: featured updates to the NCCN guidelines. J Natl Compr Canc Netw. 2013;11(5):531-546. Accessed 28 Jan 2014. PMID: 23667204
  2. Waddell T, Verheji M, Allum W, et al. Gastric cancer: ESMO-ESSO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013 Oct;24(Suppl 6):vi57-vi63. doi: 10.1093/annonc/mdt344. Accessed 28 Jan 2014. PMID: 24078663
  3. American Cancer Society. Stomach Cancer. American Cancer Society. http://www.cancer.org/.
  4. National Comprehensive Cancer Network. NCCN Clinical practice guidelines in oncology: gastric cancer (including cancer in the proximal 5 cm of the stomach) version 2.2013. National Comprehensive Cancer Network. http://www.nccn.org/.
  5. National Comprehensive Cancer Network. NCCN Clinical practice guidelines in oncology: gastric cancer version 1.2014. National Comprehensive Cancer Network. http://www.nccn.org/.
  6. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14(2):101-112. doi: 10.1007/s1020-011-0041-5. Accessed 9 Sep 2014. PMID: 21573743
  7. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: gastric cancer version 1.2015. NCCN web site. http://www.nccn.org/. 08 Jan 2015. Accessed 18 Feb 2015.
  8. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: gastric cancer version 3.2016. NCCN website. https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf. Aug 2016.
  9. Smyth EC, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D; ESMO Guidelines Committee. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016 Sep;27(Suppl 5):v38-v49. https://annonc.oxfordjournals.org/. Accessed 03 Nov 2016. PMID: 27664260
  10. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: gastric cancer version 3.2015. NCCN. http://www.nccn.org/. 23 Mar 2015. Accessed 31 Mar 2016.
  11. Bendell J, Yoon HH. Initial systemic therapy for locally advanced unresectable and metastatic esophageal and gastric cancer. UpToDate. https://www.uptodate.com. 19 Nov 2020.
  12. Bendell J, Yoon HH. Progressive, locally advanced unresectable, and metastatic esophageal and gastric cancer: approach to later lines of systemic therapy. UpToDate. https://www.uptodate.com. 18 Nov 2020.
  13. Chan AO, Wong B. Risk factors for gastric cancer. UpToDate. https://www.uptodate.com. 09 Apr 2020.
  14. ECOG-ACRIN Cancer Research Group. ECOG performance status. ECOG-ACRIN Cancer Research Group. https://www.ecog-acrin.org. 2020.
  15. ESMO Guidelines Committee. e-Update – gastric cancer treatment recommendations. ESMO. https://www.esmo.org/. 06 May 2019.
  16. ESMO Guidelines Committee. e-Update – gastric cancer treatment recommendations. ESMO. https://www.esmo.org/. 04 Nov 2019.
  17. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer. 2020 Feb. doi: 10.1007/s10120-020-01042-y. PMID: 32060757
  18. Mamon H, Enzinger PC. Adjuvant and neoadjuvant treatment of gastric cancer. UpToDate. https://www.uptodate.com. 11 Dec 2020.
  19. Mansfield PF. Clinical features, diagnosis, and staging of gastric cancer. UpToDate. https://www.uptodate.com. 01 Jun 2020.
  20. Mansfield PF. Surgical management of invasive gastric cancer. UpToDate. https://www.uptodate.com. 11 Aug 2020.
  21. Morgan D. Early gastric cancer: treatment, natural history, and prognosis. UpToDate. https://www.uptodate.com. 24 Sep 2020.
  22. National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology (NCCN guidelines): Gastric cancer. Version 3.2020. NCCN. https://www.nccn.org/. 14 Aug 2020.
  23. PDQ® Adult Treatment Editorial Board. PDQ Gastric Cancer Treatment. Bethesda, MD: National Cancer Institute. National Cancer Institute. 2020 May. https://www.cancer.gov/. PMID: 26389209
  24. Wöll E, Eisterer W, Gerger A, et al. Treatment algorithm for patients with gastric adenocarcinoma: an Austrian consensus on systemic therapy. Anticancer Res. 2019 Sep;39(9):4589-4596. doi: 10.21873/anticanres.13638. PMID: 31519555
  25. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology (NCCN guidelines): Gastric cancer. Version 2.2022. NCCN. https://www.nccn.org/. 11 Jan 2022.
  26. Ono H, Yao K, Fujishiro M, et al. Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer (second edition). Dig Endosc. 2021 Jan;33(1):4-20. doi: 10.1111/den.13883. PMID: 33107115
  27. PDQ® Adult Treatment Editorial Board. PDQ gastric cancer treatment. National Cancer Institute. https://www.cancer.gov/. 27 Jan 2022.
  28. Yoon HH. Progressive, locally advanced unresectable, and metastatic esophageal and gastric cancer: approach to later lines of systemic therapy. UpToDate. https://www.uptodate.com. 13 Apr 2022.
Editor's Recommendations
Special Reports